Minimally invasive neurosurgical devices market seen reaching $4.32 billion by 2030

The Business Research Company says the minimally invasive neurosurgical devices market will grow from $3.04 billion in 2025 to $3.27 billion in 2026, with demand driven by neurological disorders, imaging advances and robotic surgery. The report also points to North America as the largest market in 2025 and Asia-Pacific as the fastest-growing region through 2030.

Why it matters: - The market sits at the intersection of rising neurological disease burden and demand for less invasive surgery. - Growth in these devices could improve precision, reduce complications and shorten recovery times for brain and spine procedures. - The report frames the category as a growth area for hospitals, device makers and surgical centers.

What happened: - The Business Research Company released a report on the global minimally invasive neurosurgical devices market on Aug. 18, 2026, in London. - The report estimates the market will rise from $3.04 billion in 2025 to $3.27 billion in 2026, a 7.6% compound annual growth rate. - The report forecasts the market will reach $4.32 billion by 2030, with a 7.2% compound annual growth rate over the forecast period. - A free sample of the report is available here. - The full report is available here.

The details: - Minimally invasive neurosurgical devices are specialized tools and technologies used to perform neurosurgical procedures through small incisions or natural body openings. - These devices are designed to reduce trauma to surrounding tissue and support faster recovery than traditional open brain or spinal surgery. - The report cites growth drivers including more neurological disorder cases, higher neurosurgical procedure volumes, advances in endoscopic imaging, more surgeons trained in these techniques and hospital investment in surgical infrastructure. - Expected growth through 2030 is tied to AI-powered surgical navigation, wider use of robotic-assisted neurosurgery, demand for minimally invasive spinal surgery, real-time intraoperative imaging and expansion of ambulatory surgical centers. - The report highlights increasing use of image-guided procedures, robotic technologies, miniaturized instruments, outpatient and short-stay operations, and endoscopic and keyhole neurosurgery. - North America was the largest market in 2025 because of advanced healthcare infrastructure, broad adoption of new technologies and high healthcare spending. - Asia-Pacific is expected to be the fastest-growing region during the forecast period because of rising healthcare investment, growing awareness, expanding patient populations and better access to neurosurgical care. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The report package includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology and future trend analysis, and updated graphics and tables.

Between the lines: - The report suggests the market is moving from a technology niche toward broader clinical adoption. - The emphasis on robotics, AI navigation and outpatient procedures points to a push for faster, more precise surgery with lower system costs. - The Alzheimer’s Association reported in March 2023 that about 6.7 million Americans age 65 and older were living with Alzheimer’s dementia, with that figure projected to reach 13.8 million by 2060. - That kind of patient growth underscores why device makers are betting on demand for more advanced neurosurgical tools.

What's next: - The market is expected to keep expanding as hospitals, ambulatory centers and surgeons adopt more image-guided and robotic systems. - Future growth will likely depend on how quickly AI-enabled navigation, real-time imaging and miniaturized instruments move into routine clinical use. - Regional momentum is expected to stay strongest in North America and Asia-Pacific, with additional opportunities across other major global markets.

The bottom line: - Minimally invasive neurosurgical devices are moving into a stronger growth phase as neurological disease rates rise and surgery becomes more precise, less invasive and more outpatient-friendly.